Cita APA (7a ed.)

Inoue, K., Masumoto, M., Wakakura, M., & al, e. (2011). Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months. Dove Medical Press.

Cita Chicago Style (17a ed.)

Inoue, Kenji, Mieko Masumoto, Masato Wakakura, y et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.

Cita MLA (8a ed.)

Inoue, Kenji, et al. Ocular Hypotensive Effect, Preservation of Visual Fields, and Safety of Adding Dorzolamide to Prostaglandin Therapy for Twelve Months. Dove Medical Press, 2011.